HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Figures Only Full Text Full Text (PDF) Submit a response Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Ahmed, M. Articles by Goldberg, S. N. Search for Related Content PubMed PubMed Citation Articles by Ahmed, M. Articles by Goldberg, S. N.

Combination Radiofrequency Ablation with Intratumoral Liposomal Doxorubicin: Effect on Drug Accumulation and Coagulation in Multiple Tissues and Tumor Types in Animals¹

¹ From the Department of Radiology, Beth Israel Deaconess Medical Center, 330 Brookline Ave, Boston, MA 02215 (M.A., Z.L., C.H., W.L.M., S.N.G.); Department of Medical Oncology, Dana Farber Cancer Institute–Harvard Medical School, Boston, Mass (A.N.L., V.P.T.); and Department of Pharmaceutical Sciences, Bouve College of Health Sciences, Northeastern University, Boston, Mass (S.S.). From the 2003 RSNA Annual Meeting. Received November 18, 2003; revision requested January 21, 2004; final revision received August 2; accepted August 17. Supported by a grant from the National Cancer Institute, National Institutes of Health, Bethesda, Md (RO1-CA87992-01A1), and Bracco Research, Milan, Italy. Address correspondence to S.N.G. (e-mail: sgoldber@caregroup.harvard.edu).

PURPOSE: To determine whether use of radiofrequency (RF) ablation combined with intravenously (IV) administered liposomal doxorubicin, as compared with use of RF ablation or doxorubicin alone, facilitates increased tissue coagulation and interstitial drug accumulation in animal models.

MATERIALS AND METHODS: The institutional animal care and use committee approved this study. In experiment 1, multiple canine sarcomas were implanted in seven mildly immunosuppressed dogs and grown to a mean diameter of 4.8 cm. Tumors were assigned to three treatment groups: internally cooled RF ablation (12 minutes, 2000-mA pulsed technique) followed by IV liposomal doxorubicin (10 mg per animal) (n = 6), RF ablation alone (n = 6), and liposomal doxorubicin alone (n = 4). In experiment 2, the livers and kidneys of 10 rabbits and the thigh muscles of 10 rats were randomly assigned to one of two treatment groups: conventional RF ablation (90°C ± 2, 5 minutes) followed by IV liposomal doxorubicin (5 mg per rabbit, 1 mg per rat) or RF ablation alone (n = 5, each). Coagulation diameter and interstitial doxorubicin concentration (tissues were homogenized in acid alcohol, with doxorubicin extracted for 24 hours at 5°C and quantified with fluorimetry) were measured 48 hours after treatment and compared. Multivariate analysis of variance and subsequent pairwise t tests ( = .05, two-tailed test) were performed.

RESULTS: Data are means ± standard errors of the mean. A larger diameter of tumor destruction was observed in canine sarcomas treated with RF ablation–liposomal doxorubicin (3.7 cm ± 0.6) compared with that in tumors treated with RF ablation (2.3 cm ± 0.1) or liposomal doxorubicin (0.0 cm ± 0.0) alone (P < .01). A new finding was a completely necrotic red zone (1.6 cm ± 0.7) surrounding the central RF ablation–induced white coagulation zone. Greater but nonuniform drug uptake was observed particularly in this red zone (77.0 ng/g ± 18.2) compared with uptake in the central zone (15.1 ng/g ± 3.2), peripheral area of untreated tumor (38.9 ng/g ± 8.0), and tumors treated with liposomal doxorubicin alone (43.9 ng/g ± 6.7 for all regions) (P < .01 for all individual comparisons). In experiment 2, use of combined therapy led to increased coagulation in all tissues (liver: 17.6 mm ± 3.1, P = .03; kidney: 11.0 mm ± 3.1, P = .03; muscle: 13.1 mm ± 1.3, P < .01) compared with use of RF ablation alone (liver, 13.4 mm ± 1.5; kidney, 7.9 mm ± 0.7; muscle, 8.6 mm ± 0.5). Combined therapy, as compared with liposomal doxorubicin therapy alone, was also associated with increased doxorubicin accumulation in liver, kidney, and muscle (1.56 µg/g ± 0.34, 4.36 µg/g ± 1.78, and 3.63 µg/g ± 1.43, respectively, vs 1.00 µg/g ± 0.18, 1.23 µg/g ± 0.32, and 0.87 µg/g ± 0.53, respectively) (P .01 for all individual comparisons).

CONCLUSION: Use of RF ablation combined with liposomal doxorubicin facilitates increased tissue coagulation and interstitial doxorubicin accumulation in multiple tissues and tumor types and may be useful for treatment of large tumors and achieving an ablative margin within the untreated tissue surrounding RF ablation–treated tumors.

© RSNA, 2005

This article has been cited by other articles:

				C. Schraml, C. Aube, H. Graf, A. Boss, S. Clasen, T. Herberts, D. Schmidt, F. Schick, C. D. Claussen, and P. L. Pereira MR-guided Radiofrequency Ablation: Do Magnetic Fields Influence Extent of Coagulation in ex Vivo Bovine Livers? Radiology, December 1, 2006; 241(3): 746 - 752. [Abstract] [Full Text] [PDF]